Abaxis Inc logo

ABAX - Abaxis Inc Share Price

$83 -0.1  -0.1%

Last Trade - 31/07/18

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £180.0m
Position in Universe th / 7397
Unlock ABAX Revenue
Relative Strength (%)
1m +3.60%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
180.9 162 202.6 218.9 227.2 244.7 279.2 299.7 +6.2%
+53.9 -19.9 +27.0 +48.7 +5.9 -7.7 +14.6 +12.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2018, Abaxis Increvenues increased 8% to $244.7M. Net income beforeextraordinary items decreased 6% to $30.7M. Revenuesreflect Veterinary Market segment increase of 8% to $201.9M, Medical Market segment increase of 5% to $38.6M, NorthAmerica segment increase of 7% to $194.7M, Europe segmentincrease of 10% to $36.2M. Net income was offset by Salesand marketing - other increase of 15% to $48.9M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ABAX Revenue Unlock ABAX Revenue

Net Income

ABAX Net Income Unlock ABAX Revenue

Normalised EPS

ABAX Normalised EPS Unlock ABAX Revenue

PE Ratio Range

ABAX PE Ratio Range Unlock ABAX Revenue

Dividend Yield Range

ABAX Dividend Yield Range Unlock ABAX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2022
31st Dec 2023
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ABAX EPS Forecasts Unlock ABAX Revenue
Profile Summary

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Last Annual March 31st, 2018
Last Interim March 31st, 2018
Incorporated January 12, 1989
Public Since January 23, 1992
No. of Shareholders: 77
No. of Employees: 656
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange NASDAQ Global Select Market
Shares in Issue 22,698,000
Free Float (0.0%)
Eligible for
ABAX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ABAX
Upcoming Events for ABAX
Frequently Asked Questions for Abaxis Inc
What is the Abaxis Inc share price?

As of 31/07/18, shares in Abaxis Inc are trading at $83, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Abaxis Inc share price performed this year?

Shares in Abaxis Inc are currently trading at $83 and the price has moved by 76.6% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Abaxis Inc price has moved by 50.12% over the past year.

What are the analyst and broker recommendations for Abaxis Inc?

Of the analysts with advisory recommendations for Abaxis Inc, there are there are currently 1 "buy" , 6 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Abaxis Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Abaxis Inc next release its financial results?

Abaxis Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-03-31
What is the Abaxis Inc dividend yield?

The Abaxis Inc dividend yield is % based on the trailing twelve month period.

Does Abaxis Inc pay a dividend?

Last year, Abaxis Inc paid a total dividend of 0.6, and it currently has a trailing dividend yield of %. Looking ahead, Abaxis Inc has not announced an ex-dividend date yet.

When does Abaxis Inc next pay dividends?

Abaxis Inc has yet to annouce their ex-dividend date. The historic dividend yield on Abaxis Inc shares is currently %.

How do I buy Abaxis Inc shares?

To buy shares in Abaxis Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Abaxis Inc?

Shares in Abaxis Inc are currently trading at $83, giving the company a market capitalisation of £n/a.

Where are Abaxis Inc shares listed? Where are Abaxis Inc shares listed?

Here are the trading details for Abaxis Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ABAX
What kind of share is Abaxis Inc?

We were not able to load our ranking data for Abaxis Inc

Is there a Abaxis Inc share price forecast 2022?

We were not able to load any forecast data for Abaxis Inc.

How can I tell whether the Abaxis Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abaxis Inc. Over the past six months, the relative strength of its shares against the market has been 11.42%. At the current price of $83, shares in Abaxis Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Abaxis Inc PE Ratio?

We were not able to find PE ratio data for Abaxis Inc.

Who are the key directors of Abaxis Inc?

Abaxis Inc's management team is headed by:

Clinton Severson - CEO
Kenneth Aron - CTO
Donald Wood - PRE
Achim Henkel - OTH
Craig Tockman - VPR
Ross Taylor - CFO
Who are the major shareholders of Abaxis Inc?

Here are the top five shareholders of Abaxis Inc based on the size of their shareholding:

Similar to ABAX
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.